undamentalytics Newsletter
Sign in

Cronos Group Inc. revenue

Cronos Group Inc.'s revenue was $147m in fiscal 2025, up 24.6% on the year before. Since fiscal 2017 ($3.1m) it has grown at a compound 61.6% a year. Over the last twelve months it was $179m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue3122447658787118147179
Growth on the year before—+285.2%+95.9%+96.7%+38.2%+34.4%+0.6%+34.8%+24.6%—
Gross profit26−18−26−181512256382
Gross margin50.0%51.3%−74.1%−55.3%−27.3%17.8%13.7%21.4%42.8%45.9%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue YoY
Cannabis Flower $108M ▲ 23.4%
Cannabis Extracts $37.7M ▲ 29.3%
Other $411,000 ▼ 23.2%

These categories overlap or exclude eliminations, so shares aren't shown.

Geography
Region Revenue YoY
Canada $90.3M ▲ 9.6%
Israel $41.8M ▲ 47.3%
Other Countries $14.5M ▲ 112.3%

These categories overlap or exclude eliminations, so shares aren't shown.

From Cronos Group Inc.'s 10-K filed February 26, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Pharmaceuticals: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Cronos Group Inc. $179m 37.5% 30.3%
Kamada LTD $180m 12.1% —
Amarin Corp plc\uk $176m -22.3% -18.3%
Biote Corp. $184m -7.8% 0.5%
Organigram Global Inc. $185m 57.8% —
Heron Therapeutics, Inc. $151m 1.0% 8.6%

Compare with peers

Head to head: CRON vs KMDAAMRN vs CRONBTMD vs CRONCRON vs OGI

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Cronos Group Inc.'s SEC filings (10-K and 10-Q), retrieved October 31, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Cronos Group Inc.